NBTX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Nanobiotix

NASDAQ | NBTX

22.62

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$1.33B

Market Cap

-

P/E Ratio

-1.22

EPS

$30.35

52 Week High

$2.76

52 Week Low

HEALTHCARE

Sector

NBTX Chart

Recent Chart
Price Action

NBTX Technicals

Tags:

NBTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit -$12M
Total Revenue -$12M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$68M
Selling General And Administrative $20M
Research And Development $41M
Operating Expenses $57M
Investment Income Net -
Net Interest Income -$2.6M
Interest Income $2.6M
Interest Expense $8.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$68M
Income Tax Expense $101K
Interest And Debt Expense -
Net Income From Continuing Operations -$68M
Comprehensive Income Net Of Tax -
Ebit -$60M
Ebitda -$58M
Net Income -$68M

Revenue & Profitability

Earnings Performance

NBTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (EUR)
Total Assets $67M
Total Current Assets $61M
Cash And Cash Equivalents At Carrying Value $50M
Cash And Short Term Investments $50M
Inventory -
Current Net Receivables $8.5M
Total Non Current Assets $6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $7K
Intangible Assets Excluding Goodwill $7K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.2M
Other Non Current Assets -
Total Liabilities $133M
Total Current Liabilities $59M
Current Accounts Payable $4.5M
Deferred Revenue -
Current Debt -
Short Term Debt $4.9M
Total Non Current Liabilities $74M
Capital Lease Obligations $4.2M
Long Term Debt $43M
Current Long Term Debt $3.7M
Long Term Debt Noncurrent -
Short Long Term Debt Total $51M
Other Current Liabilities $24M
Other Non Current Liabilities $28M
Total Shareholder Equity -$66M
Treasury Stock -
Retained Earnings -$68M
Common Stock $1.4M
Common Stock Shares Outstanding $47M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (EUR)
Operating Cashflow -$20M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $848K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$955K
Cashflow From Financing -$5.1M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $0
Dividend Payout Common Stock $0
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$68M

yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit -$12M
Total Revenue -$12M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$68M
Selling General And Administrative $20M
Research And Development $41M
Operating Expenses $57M
Investment Income Net -
Net Interest Income -$2.6M
Interest Income $2.6M
Interest Expense $8.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$68M
Income Tax Expense $101K
Interest And Debt Expense -
Net Income From Continuing Operations -$68M
Comprehensive Income Net Of Tax -
Ebit -$60M
Ebitda -$58M
Net Income -$68M

NBTX News

NBTX Profile

Nanobiotix Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Nanobiotix SA is a leading clinical-stage biotechnology company headquartered in Paris, France, focused on transforming cancer treatment through its innovative nanotechnology platform. The company is dedicated to developing localized cancer therapies designed to augment the effectiveness of existing treatments while reducing side effects. With a diverse pipeline of candidates in various clinical trial phases, Nanobiotix is strategically positioned to be a key player in oncology, leveraging its unique scientific approach to enhance patient outcomes. Through ongoing partnerships and collaborations, Nanobiotix aims to redefine treatment paradigms and deliver groundbreaking solutions for cancer patients globally.

BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.19%
$26.05
AIRE
+61.36%
$0.72
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
ETHD
-0.53%
$3.73
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
GRAB
-1.23%
$5.60
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
VALE
-1.14%
$11.27
BTBT
-8.29%
$3.87
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
ADD
-25.47%
$0.05
AAL
+1.47%
$12.35
GPUS
-7.57%
$0.36
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
AMC
+3.61%
$2.87
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
AG
-11.21%
$12.75
CORZ
+2.23%
$19.23
UAMY
-7.74%
$12.39
BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+28.69%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.19%
$26.05
AIRE
+61.36%
$0.72
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
ETHD
-0.53%
$3.73
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
GRAB
-1.23%
$5.60
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
VALE
-1.14%
$11.27
BTBT
-8.29%
$3.87
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
ADD
-25.47%
$0.05
AAL
+1.47%
$12.35
GPUS
-7.57%
$0.36
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
AMC
+3.61%
$2.87
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
AG
-11.21%
$12.75
CORZ
+2.23%
$19.23
UAMY
-7.74%
$12.39
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.